Drug Approval | March 19, 2025
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
Alkem Medtech to acquire 100% stake of Bombay Ortho
Alkem Medtech to acquire 100% stake of Bombay Ortho
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Experts urge early detection & better access to care
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
The programme will take place on the 2nd Sunday of every month
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Announces Rs. 317 crore investment in new recycling plant
This e-commerce platform is launched as a hyperlocal model
Subscribe To Our Newsletter & Stay Updated
